RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KMPharmaceutical Co

KMPharmaceutical Co Debt 2024

KMPharmaceutical Co Debt

12,820.52 KRW

KMPharmaceutical Co Dividend yield

Ticker

225430.KQ

ISIN

KR7225430008

In 2024, KMPharmaceutical Co's total debt was 12,820.52 KRW, a 69.81% change from the 7,549.86 KRW total debt recorded in the previous year.

KMPharmaceutical Co Aktienanalyse

What does KMPharmaceutical Co do?

KMPharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding KMPharmaceutical Co's Debt Structure

KMPharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing KMPharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to KMPharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in KMPharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about KMPharmaceutical Co Stock

What is the debt of KMPharmaceutical Co this year?

KMPharmaceutical Co has a debt level of 12,820.52 KRW this year.

What was the debt of KMPharmaceutical Co compared to the previous year?

The debt of KMPharmaceutical Co has increased by 69.81% compared to the previous year increased.

What are the consequences of high debt for investors in KMPharmaceutical Co?

High debt can pose a risk for investors of KMPharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of KMPharmaceutical Co?

Low debt means that KMPharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from KMPharmaceutical Co affect the company?

An increase in debt of KMPharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of KMPharmaceutical Co affect the company?

A reduction in debt of KMPharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of KMPharmaceutical Co?

Some factors that can influence the debt of KMPharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of KMPharmaceutical Co so important for investors?

The debts of KMPharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can KMPharmaceutical Co take to change the debt?

To change the debt, KMPharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does KMPharmaceutical Co pay?

Over the past 12 months, KMPharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KMPharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of KMPharmaceutical Co?

The current dividend yield of KMPharmaceutical Co is .

When does KMPharmaceutical Co pay dividends?

KMPharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KMPharmaceutical Co?

KMPharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of KMPharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is KMPharmaceutical Co located?

KMPharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von KMPharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KMPharmaceutical Co from 6/5/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 6/5/2024.

When did KMPharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/5/2024.

What was the dividend of KMPharmaceutical Co in the year 2023?

In the year 2023, KMPharmaceutical Co distributed 0 KRW as dividends.

In which currency does KMPharmaceutical Co pay out the dividend?

The dividends of KMPharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KMPharmaceutical Co

Our stock analysis for KMPharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KMPharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.